MX340829B - Branched soluble glucose polymers for peritoneal dialysis. - Google Patents

Branched soluble glucose polymers for peritoneal dialysis.

Info

Publication number
MX340829B
MX340829B MX2012008919A MX2012008919A MX340829B MX 340829 B MX340829 B MX 340829B MX 2012008919 A MX2012008919 A MX 2012008919A MX 2012008919 A MX2012008919 A MX 2012008919A MX 340829 B MX340829 B MX 340829B
Authority
MX
Mexico
Prior art keywords
glucose polymers
peritoneal dialysis
soluble glucose
branched soluble
content
Prior art date
Application number
MX2012008919A
Other languages
Spanish (es)
Other versions
MX2012008919A (en
Inventor
Carole Petitjean
Daniel Wils
Laëtitia Guerin-Deremaux
Original Assignee
Roquette Freres *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres * filed Critical Roquette Freres *
Publication of MX2012008919A publication Critical patent/MX2012008919A/en
Publication of MX340829B publication Critical patent/MX340829B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18—Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12—Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/20—Amylose or amylopectin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to branched soluble glucose polymers made of starch having an amylose content of at least 30 wt %, preferably 35 wt % to 80 wt %, having a glycosidic linkage a-1,6 content of 7% to 10%, preferably 8% to 9%, and a MW of 50,000 to 150,000 daltons, characterised in that said polymers are resistant to pancreatic alpha amylase, expressed according to a test "B" for a reducing sugar content of 25% to 35%, and a MW of released products of 6,000 to 12,000 daltons.
MX2012008919A 2010-02-02 2011-02-01 Branched soluble glucose polymers for peritoneal dialysis. MX340829B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1050736A FR2955861B1 (en) 2010-02-02 2010-02-02 SOLUBLE GLUCOSE BRANCHES POLYMERS FOR PERITONEAL DIALYSIS
PCT/FR2011/050201 WO2011095736A1 (en) 2010-02-02 2011-02-01 Branched soluble glucose polymers for peritoneal dialysis

Publications (2)

Publication Number Publication Date
MX2012008919A MX2012008919A (en) 2012-08-15
MX340829B true MX340829B (en) 2016-07-26

Family

ID=42340838

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008919A MX340829B (en) 2010-02-02 2011-02-01 Branched soluble glucose polymers for peritoneal dialysis.

Country Status (11)

Country Link
US (1) US9200087B2 (en)
EP (1) EP2531531B1 (en)
JP (1) JP5822402B2 (en)
CN (1) CN102741296B (en)
BR (1) BR112012019136B1 (en)
CA (1) CA2786428C (en)
ES (1) ES2931925T3 (en)
FR (1) FR2955861B1 (en)
MX (1) MX340829B (en)
PL (1) PL2531531T3 (en)
WO (1) WO2011095736A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2906984A1 (en) 2013-03-15 2014-09-18 Cargill, Incorporated Carbohydrate compositions
CN105524181B (en) * 2014-10-23 2017-12-08 华仁药业股份有限公司 The brand-new synthesis technique of Icodextrin bulk drug
CN104544473A (en) * 2014-12-08 2015-04-29 江南大学 Biological modification method for inhibiting starch retrogradation
DE102015014699A1 (en) 2015-11-13 2017-05-18 Fresenius Medical Care Deutschland Gmbh Dialysis solution with at least one osmoticum
WO2017211376A1 (en) * 2016-06-11 2017-12-14 Gea Tds Gmbh Method and system for purifying liquid sugar produced from granulated sugar of low purity
FR3055898B1 (en) * 2016-09-15 2018-11-02 Roquette Freres NOVEL GLUCOSE POLYMERS FOR PERITONEAL DIALYSIS
EP3381484A1 (en) * 2017-03-31 2018-10-03 Opterion Health AG Carbohydrate composition for dialysis
CN108020576A (en) * 2017-10-12 2018-05-11 青岛力腾化工医药研究有限公司 One kind is using nuclear magnetic resonance to glucose polymer degree of branching method for measuring
FR3077959B1 (en) * 2018-02-22 2021-09-24 Roquette Freres PROCESS FOR MANUFACTURING RESISTANT PEA DEXTRIN
CN111215017B (en) * 2019-12-10 2021-06-25 山东省鲁洲食品集团有限公司 Device and method for preventing liquid dextrin from aging in storage process
WO2023159172A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins
WO2023159173A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins
WO2023159171A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins
WO2023159175A1 (en) 2022-02-17 2023-08-24 Cargill, Incorporated Resistant dextrins and methods of making resistant dextrins

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1444901A (en) * 1972-05-02 1976-08-04 Milner Scient Medical Research Glucose polymers
EP0207676B1 (en) 1985-06-22 1994-06-01 M L Laboratories Plc Polymers for use in continuous peritoneal dialysis
FR2716199B1 (en) * 1994-02-15 1996-04-26 Roquette Freres Process for the manufacture of a starch hydrolyzate with a low polymolecularity index, a new starch hydrolyzate thus obtained and its use in peritoneal dialysis.
US5922379A (en) * 1998-05-05 1999-07-13 Natural Polymer International Corporation Biodegradable protein/starch-based thermoplastic composition
FR2792941B1 (en) * 1999-04-30 2001-07-27 Roquette Freres SOLUBLE BRANCHED GLUCOSE POLYMERS AND PROCESS FOR OBTAINING SAME
US20020065410A1 (en) * 1999-12-02 2002-05-30 Antrim Richard L. Branched starches and branched starch hydrolyzates
US20020018837A1 (en) * 2000-05-27 2002-02-14 Lanner David Arthur Dough for making tortilla chips with controlled surface bubbling
US7709230B2 (en) * 2001-04-27 2010-05-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing isomaltose and uses thereof
FR2840612B1 (en) 2002-06-06 2005-05-06 Roquette Freres HIGHLY BRANCHED SOLUBLE GLUCOSE POLYMERS AND PROCESS FOR OBTAINING THEM
WO2003106502A1 (en) * 2002-06-17 2003-12-24 Novozymes A/S Methods for producing dextrins using enzymes
DE10237442B4 (en) 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Highly branched, low substituted starch products
FR2864088B1 (en) * 2003-12-19 2006-04-28 Roquette Freres SOLUBLE POLYMERS OF HIGHLY BRANCHED GLUCOSE
US7118857B2 (en) 2004-02-27 2006-10-10 Baxter International Inc. Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions
JP5307387B2 (en) * 2004-09-30 2013-10-02 江崎グリコ株式会社 Highly branched and high molecular weight glycogen
FR2897869B1 (en) 2006-02-28 2011-05-06 Roquette Freres HIGHLY BRANCHED GLUCOSE SOLUBLE POLYMERS FOR ENTERAL AND PARENTAL NUTRITION AND FOR PERITONEAL DIALYSIS
EP1943908A1 (en) * 2006-12-29 2008-07-16 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Novel slowly digestible storage carbohydrate
KR100868329B1 (en) * 2007-02-01 2008-11-12 씨제이제일제당 (주) A method for preparing enzymatically highly branched-amylose and amylopectin cluster
CN100509854C (en) * 2007-04-19 2009-07-08 成都新柯力化工科技有限公司 Method for preparing amylose

Also Published As

Publication number Publication date
BR112012019136B1 (en) 2021-01-19
CN102741296B (en) 2016-03-02
JP2013518562A (en) 2013-05-23
JP5822402B2 (en) 2015-11-24
US20120295873A1 (en) 2012-11-22
EP2531531A1 (en) 2012-12-12
PL2531531T3 (en) 2022-12-19
ES2931925T3 (en) 2023-01-04
CA2786428A1 (en) 2011-08-11
EP2531531B1 (en) 2022-09-14
MX2012008919A (en) 2012-08-15
US9200087B2 (en) 2015-12-01
BR112012019136A2 (en) 2018-03-27
CA2786428C (en) 2017-07-18
FR2955861A1 (en) 2011-08-05
CN102741296A (en) 2012-10-17
FR2955861B1 (en) 2013-03-22
WO2011095736A1 (en) 2011-08-11

Similar Documents

Publication Publication Date Title
MX340829B (en) Branched soluble glucose polymers for peritoneal dialysis.
IN2015DN01881A (en)
IN2012DN05020A (en)
MY158319A (en) Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
WO2009093023A3 (en) Multilayer scaffold
WO2009049284A3 (en) Compositions and methods for improved glycoprotein sialylation
AU2010245761A8 (en) Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
MY184985A (en) Oligosaccharide mixture and food product comprising this mixture, especially infant formula
AR065381A1 (en) PRODUCTION OF RESISTANT AMILACEO PRODUCT
WO2012008722A3 (en) Filler composition for tissue reinforcement
WO2008082298A3 (en) Novel slowly digestible storage carbohydrate
BR112013002875A2 (en) carbohydrate compositions
MX2009006119A (en) Fibers comprising hemicellulose and processes for making same.
NZ600916A (en) Dietary fibre composition containing beta-glucan
WO2010023422A8 (en) Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
NO20080943L (en) Preparation of crystalline short chain amylose
WO2009143119A3 (en) Absorbent product comprising a cationic modified starch
MX2014011394A (en) Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient.
WO2011005853A3 (en) Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome
BR112012009359A2 (en) potato product with higher resistant starch content and moderate glycemic response and respective methods
IN2012DN02423A (en)
MY168759A (en) Pharmaceutical compositions comprising modified fucans and methods relating thereto
NZ603479A (en) Chitosan composition
MX358560B (en) Food products comprising hydrolyzed whole grain.
WO2008096547A1 (en) Anti-tumor composition comprising tissue-accumulating chitosan gel

Legal Events

Date Code Title Description
FG Grant or registration